Publications

Detailed Information

Consensus statement on iron overload in myelodysplastic syndromes

DC Field Value Language
dc.contributor.authorBennett, John M-
dc.date.accessioned2010-03-31T06:46:47Z-
dc.date.available2010-03-31T06:46:47Z-
dc.date.issued2008-09-04-
dc.identifier.citationAm J Hematol. 2008 ;83(11):858-61.en
dc.identifier.issn1096-8652 (Electronic)-
dc.identifier.urihttps://hdl.handle.net/10371/62224-
dc.description.abstractIn May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on Myelodysplastic Syndromes in Florence Italy, May 2007. The recommendations of the consensus working group are presented here. The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; NCCN practice guidelines: Myelodysplastic Syndromes, version 2.2008).en
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.subjectChelation Therapy/*standardsen
dc.subjectErythrocyte Transfusion/adverse effects/*standardsen
dc.subjectFerritins/blooden
dc.subjectHumansen
dc.subjectIron/metabolismen
dc.subjectIron Overload/etiology/*prevention & controlen
dc.subjectMyelodysplastic Syndromes/*therapyen
dc.titleConsensus statement on iron overload in myelodysplastic syndromesen
dc.typeArticleen
dc.identifier.doi10.1002/ajh.21269-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share